HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Ophthalmology
Meta-analysis
Perioperative anti-VEGF injections improve vision and reduce bleeding in proliferative diabetic retinopathy
Anti-VEGF injections before eye surgery improve vision and reduce bleeding in diabetic retinopathy
This network meta-analysis evaluated the timing of perioperative anti-VEGF injections for proliferative diabetic retinopathy. Results indica…
A network meta-analysis of 2,646 eyes found that perioperative anti-VEGF injections improved vision and reduced bleeding in patients with pr…
Jun 1, 2026
Rheumatology
Sys. Review
Integrated care combining antiangiogenic bridging and ischemia-directed therapies supports long-term success in neovascular glaucoma management
Integrated care offers long-term success for neovascular glaucoma
This narrative review addresses neovascular glaucoma management in patients with retinal ischemia. The authors argue that long-term success …
A review suggests combining antiangiogenic bridging with ischemia management and surgery may help patients with neovascular glaucoma achieve…
Frontiers
May 29, 2026
Rheumatology
Meta-analysis
Meta-analysis of ROP treatments finds anti-VEGF linked to less myopia than laser or surgery
Anti-VEGF Treatment Leads To Better Vision Outcomes For Premature Babies
This systematic review and meta-analysis of 10,269 eyes found anti-VEGF treatment for retinopathy of prematurity was associated with the lea…
New research shows that anti-VEGF injections lead to better long-term vision for premature babies than laser or freezing methods.
Frontiers
May 15, 2026
Ophthalmology
Meta-analysis
Systematic review finds radiotherapy combined with anti-VEGF therapy increases risk of vision loss compared to anti-VEGF monotherapy in nAMD
Radiotherapy plus anti-VEGF therapy increases vision loss risk for nAMD
This systematic review and meta-analysis evaluated radiotherapy combined with anti-VEGF therapy versus anti-VEGF monotherapy for neovascular…
Adding radiotherapy to anti-VEGF treatment for wet macular degeneration was linked to a higher risk of vision loss compared to anti-VEGF alo…
May 1, 2026
Ophthalmology
Proteomic profiling in anti-VEGF-treated AMD patients reveals VEGF-independent immune pathway activation
Why Immune Cells Keep Damaging Your Eyes
This observational study analyzed vitreous proteomic profiles in eight patients with neovascular AMD receiving anti-VEGF therapy compared to…
Standard eye drops for AMD stop one problem, but a second, hidden immune attack is still hurting your vision.
medRxiv
Apr 14, 2026